News
Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...
BTIG analyst Ryan Zimmerman maintained a Buy rating on Treace Medical Concepts (TMCI – Research Report) today and set a price target of $14.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback